These findings indicate a trend toward reduced MACE risk in late-stage CKD, although it did not reach statistical significance.
← all excerpts
Association between statin use and major adverse cardiovascular events in patients with chronic kidney disease and cardiomyopathy: A retrospective case-control study.
1
—
—